annual CFF:
-$9.41B-$30.46B(-144.73%)Summary
- As of today (May 23, 2025), AMGN annual cash flow from financing activities is -$9.41 billion, with the most recent change of -$30.46 billion (-144.73%) on December 31, 2024.
- During the last 3 years, AMGN annual CFF has fallen by -$1.14 billion (-13.83%).
- AMGN annual CFF is now -144.73% below its all-time high of $21.05 billion, reached on December 31, 2023.
Performance
AMGN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
-$4.11B-$2.70B(-191.90%)Summary
- As of today (May 23, 2025), AMGN quarterly cash flow from financing activities is -$4.11 billion, with the most recent change of -$2.70 billion (-191.90%) on March 31, 2025.
- Over the past year, AMGN quarterly CFF has dropped by -$2.40 billion (-140.46%).
- AMGN quarterly CFF is now -119.09% below its all-time high of $21.51 billion, reached on March 31, 2023.
Performance
AMGN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$11.81B-$2.40B(-25.48%)Summary
- As of today (May 23, 2025), AMGN TTM cash flow from financing activities is -$11.81 billion, with the most recent change of -$2.40 billion (-25.48%) on March 31, 2025.
- Over the past year, AMGN TTM CFF has dropped by -$9.64 billion (-444.67%).
- AMGN TTM CFF is now -156.13% below its all-time high of $21.05 billion, reached on December 31, 2023.
Performance
AMGN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AMGN Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -144.7% | -140.5% | -444.7% |
| 3 y3 years | -13.8% | -16.9% | -20.0% |
| 5 y5 years | +40.3% | -1516.9% | -7.1% |
AMGN Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -144.7% | at low | -119.1% | at low | -156.1% | at low |
| 5 y | 5-year | -144.7% | +40.3% | -119.1% | +37.4% | -156.1% | at low |
| alltime | all time | -144.7% | +58.1% | -119.1% | +64.9% | -156.1% | +47.5% |
AMGN Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$4.11B(+191.9%) | -$11.81B(+25.5%) |
| Dec 2024 | -$9.41B(-144.7%) | -$1.41B(-61.5%) | -$9.41B(+79.2%) |
| Sep 2024 | - | -$3.65B(+37.8%) | -$5.25B(+45.6%) |
| Jun 2024 | - | -$2.65B(+55.1%) | -$3.61B(+66.3%) |
| Mar 2024 | - | -$1.71B(-162.0%) | -$2.17B(-110.3%) |
| Dec 2023 | $21.05B(-621.4%) | $2.75B(-237.4%) | $21.05B(+22.1%) |
| Sep 2023 | - | -$2.00B(+65.7%) | $17.25B(-17.2%) |
| Jun 2023 | - | -$1.21B(-105.6%) | $20.84B(-0.7%) |
| Mar 2023 | - | $21.51B(-2150.4%) | $20.99B(-619.8%) |
| Dec 2022 | -$4.04B(-51.2%) | -$1.05B(-166.1%) | -$4.04B(-57.7%) |
| Sep 2022 | - | $1.59B(-249.5%) | -$9.55B(+15.2%) |
| Jun 2022 | - | -$1.06B(-69.8%) | -$8.29B(-15.8%) |
| Mar 2022 | - | -$3.51B(-46.4%) | -$9.85B(+19.0%) |
| Dec 2021 | -$8.27B(+69.9%) | -$6.56B(-330.3%) | -$8.27B(+56.0%) |
| Sep 2021 | - | $2.85B(-208.6%) | -$5.30B(-46.7%) |
| Jun 2021 | - | -$2.62B(+35.2%) | -$9.95B(+51.8%) |
| Mar 2021 | - | -$1.94B(-46.0%) | -$6.55B(+34.6%) |
| Dec 2020 | -$4.87B(-69.1%) | -$3.59B(+99.7%) | -$4.87B(+51.8%) |
| Sep 2020 | - | -$1.80B(-332.0%) | -$3.21B(-24.9%) |
| Jun 2020 | - | $775.00M(-405.1%) | -$4.27B(-61.3%) |
| Mar 2020 | - | -$254.00M(-86.8%) | -$11.03B(-30.0%) |
| Dec 2019 | -$15.77B(-29.9%) | -$1.93B(-32.5%) | -$15.77B(-9.4%) |
| Sep 2019 | - | -$2.86B(-52.3%) | -$17.41B(+1.6%) |
| Jun 2019 | - | -$5.99B(+20.2%) | -$17.13B(+8.5%) |
| Mar 2019 | - | -$4.99B(+39.8%) | -$15.79B(-29.8%) |
| Dec 2018 | -$22.49B(+241.1%) | -$3.57B(+38.3%) | -$22.49B(+6.8%) |
| Sep 2018 | - | -$2.58B(-44.5%) | -$21.06B(+7.5%) |
| Jun 2018 | - | -$4.65B(-60.2%) | -$19.58B(+21.1%) |
| Mar 2018 | - | -$11.69B(+447.9%) | -$16.18B(+145.3%) |
| Dec 2017 | -$6.59B(+153.7%) | -$2.13B(+92.8%) | -$6.59B(+0.2%) |
| Sep 2017 | - | -$1.11B(-10.9%) | -$6.58B(+34.5%) |
| Jun 2017 | - | -$1.24B(-41.2%) | -$4.89B(-17.6%) |
| Mar 2017 | - | -$2.11B(-0.5%) | -$5.94B(+128.4%) |
| Dec 2016 | -$2.60B(-31.1%) | -$2.12B(-464.6%) | -$2.60B(+85.8%) |
| Sep 2016 | - | $582.00M(-125.5%) | -$1.40B(-59.3%) |
| Jun 2016 | - | -$2.29B(-286.3%) | -$3.44B(+199.8%) |
| Mar 2016 | - | $1.23B(-233.1%) | -$1.15B(-69.6%) |
| Dec 2015 | -$3.77B(+15.2%) | -$922.00M(-36.8%) | -$3.77B(-37.3%) |
| Sep 2015 | - | -$1.46B(<-9900.0%) | -$6.01B(+18.7%) |
| Jun 2015 | - | $6.00M(-100.4%) | -$5.07B(+21.3%) |
| Mar 2015 | - | -$1.40B(-55.8%) | -$4.18B(+27.6%) |
| Dec 2014 | -$3.27B(-220.1%) | -$3.16B(+516.4%) | -$3.27B(-188.6%) |
| Sep 2014 | - | -$513.00M(-157.3%) | $3.69B(-47.2%) |
| Jun 2014 | - | $896.00M(-281.0%) | $7.00B(+20.3%) |
| Mar 2014 | - | -$495.00M(-113.0%) | $5.82B(+113.4%) |
| Dec 2013 | $2.73B(+550.6%) | $3.81B(+36.6%) | $2.73B(-212.3%) |
| Sep 2013 | - | $2.79B(-1084.8%) | -$2.43B(-36.0%) |
| Jun 2013 | - | -$283.00M(-92.1%) | -$3.79B(+110.5%) |
| Mar 2013 | - | -$3.58B(+166.1%) | -$1.80B(-529.8%) |
| Dec 2012 | $419.00M(-162.2%) | -$1.35B(-194.6%) | $419.00M(-87.9%) |
| Sep 2012 | - | $1.42B(-16.6%) | $3.46B(-1958.6%) |
| Jun 2012 | - | $1.71B(-225.1%) | -$186.00M(-140.7%) |
| Mar 2012 | - | -$1.36B(-180.7%) | $457.00M(-167.8%) |
| Dec 2011 | -$674.00M(-45.3%) | $1.69B(-176.2%) | -$674.00M(-81.0%) |
| Sep 2011 | - | -$2.22B(-194.4%) | -$3.55B(+2879.8%) |
| Jun 2011 | - | $2.35B(-194.2%) | -$119.00M(-96.2%) |
| Mar 2011 | - | -$2.50B(+111.3%) | -$3.15B(+155.8%) |
| Dec 2010 | -$1.23B(-39.1%) | -$1.18B(-197.8%) | -$1.23B(-44.7%) |
| Sep 2010 | - | $1.21B(-276.9%) | -$2.23B(-34.1%) |
| Jun 2010 | - | -$683.00M(+18.6%) | -$3.38B(+29.8%) |
| Mar 2010 | - | -$576.00M(-73.5%) | -$2.60B(+28.7%) |
| Dec 2009 | -$2.02B(-34.1%) | -$2.18B(-4058.2%) | -$2.02B(+40.1%) |
| Sep 2009 | - | $55.00M(-40.9%) | -$1.45B(+0.7%) |
| Jun 2009 | - | $93.00M(+1760.0%) | -$1.44B(-53.5%) |
| Mar 2009 | - | $5.00M(-100.3%) | -$3.09B(+0.5%) |
| Dec 2008 | -$3.07B(+15.2%) | -$1.60B(-2558.5%) | -$3.07B(+83.7%) |
| Sep 2008 | - | $65.00M(-104.2%) | -$1.67B(-2.1%) |
| Jun 2008 | - | -$1.56B(-7533.3%) | -$1.71B(+179.7%) |
| Mar 2008 | - | $21.00M(-110.6%) | -$611.00M(-77.1%) |
| Dec 2007 | -$2.67B | -$198.00M(-782.8%) | -$2.67B(+6.0%) |
| Sep 2007 | - | $29.00M(-106.3%) | -$2.52B(-12.8%) |
| Jun 2007 | - | -$463.00M(-77.3%) | -$2.89B(-23.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2007 | - | -$2.04B(+4141.7%) | -$3.77B(+363.2%) |
| Dec 2006 | -$815.00M(-82.0%) | -$48.00M(-86.0%) | -$815.00M(-55.8%) |
| Sep 2006 | - | -$342.00M(-74.6%) | -$1.84B(+14.3%) |
| Jun 2006 | - | -$1.35B(-246.0%) | -$1.61B(+83.0%) |
| Mar 2006 | - | $924.00M(-185.7%) | -$882.00M(-80.6%) |
| Dec 2005 | -$4.54B(+182.0%) | -$1.08B(+871.2%) | -$4.54B(+95.9%) |
| Sep 2005 | - | -$111.00M(-82.0%) | -$2.32B(-33.8%) |
| Jun 2005 | - | -$617.00M(-77.4%) | -$3.50B(-7.8%) |
| Mar 2005 | - | -$2.73B(-339.0%) | -$3.80B(+136.0%) |
| Dec 2004 | -$1.61B(+17.3%) | $1.14B(-188.2%) | -$1.61B(-50.6%) |
| Sep 2004 | - | -$1.30B(+42.1%) | -$3.26B(+51.6%) |
| Jun 2004 | - | -$912.00M(+67.6%) | -$2.15B(+42.8%) |
| Mar 2004 | - | -$544.00M(+7.3%) | -$1.51B(+9.7%) |
| Dec 2003 | -$1.37B(-177.2%) | -$507.00M(+170.8%) | -$1.37B(+70.3%) |
| Sep 2003 | - | -$187.20M(-30.0%) | -$805.50M(+60.1%) |
| Jun 2003 | - | -$267.50M(-34.8%) | -$503.10M(-33.2%) |
| Mar 2003 | - | -$410.30M(-789.6%) | -$753.00M(-142.4%) |
| Dec 2002 | $1.78B(-472.0%) | $59.50M(-48.4%) | $1.78B(+14.3%) |
| Sep 2002 | - | $115.20M(-122.3%) | $1.56B(+32.4%) |
| Jun 2002 | - | -$517.40M(-124.4%) | $1.17B(-28.8%) |
| Mar 2002 | - | $2.12B(-1397.9%) | $1.65B(-445.2%) |
| Dec 2001 | -$478.00M(-4.9%) | -$163.40M(-38.5%) | -$478.00M(+17.2%) |
| Sep 2001 | - | -$265.50M(+536.7%) | -$407.80M(+6.5%) |
| Jun 2001 | - | -$41.70M(+463.5%) | -$382.80M(-19.0%) |
| Mar 2001 | - | -$7.40M(-92.1%) | -$472.80M(-5.9%) |
| Dec 2000 | -$502.70M(-26.3%) | -$93.20M(-61.2%) | -$502.70M(-26.7%) |
| Sep 2000 | - | -$240.50M(+82.6%) | -$685.50M(+26.1%) |
| Jun 2000 | - | -$131.70M(+253.1%) | -$543.60M(-15.7%) |
| Mar 2000 | - | -$37.30M(-86.5%) | -$645.10M(-5.4%) |
| Dec 1999 | -$682.00M(+68.1%) | -$276.00M(+179.9%) | -$682.00M(+51.4%) |
| Sep 1999 | - | -$98.60M(-57.7%) | -$450.40M(+3.4%) |
| Jun 1999 | - | -$233.20M(+214.3%) | -$435.70M(+139.8%) |
| Mar 1999 | - | -$74.20M(+67.1%) | -$181.70M(-55.2%) |
| Dec 1998 | -$405.80M(-23.6%) | -$44.40M(-47.1%) | -$405.80M(-26.4%) |
| Sep 1998 | - | -$83.90M(-503.4%) | -$551.60M(-19.0%) |
| Jun 1998 | - | $20.80M(-107.0%) | -$681.00M(+1.6%) |
| Mar 1998 | - | -$298.30M(+56.8%) | -$670.30M(+26.3%) |
| Dec 1997 | -$530.90M(+29.6%) | -$190.20M(-10.8%) | -$530.90M(+35.3%) |
| Sep 1997 | - | -$213.30M(-777.1%) | -$392.30M(+46.7%) |
| Jun 1997 | - | $31.50M(-119.8%) | -$267.50M(-36.8%) |
| Mar 1997 | - | -$158.90M(+207.9%) | -$423.20M(+3.3%) |
| Dec 1996 | -$409.80M(+83.2%) | -$51.60M(-41.7%) | -$409.80M(-8.7%) |
| Sep 1996 | - | -$88.50M(-28.7%) | -$448.90M(+30.8%) |
| Jun 1996 | - | -$124.20M(-14.6%) | -$343.30M(+10.7%) |
| Mar 1996 | - | -$145.50M(+60.4%) | -$310.20M(+38.7%) |
| Dec 1995 | -$223.70M(-13.3%) | -$90.70M(-630.4%) | -$223.70M(+14.2%) |
| Sep 1995 | - | $17.10M(-118.8%) | -$195.80M(-30.0%) |
| Jun 1995 | - | -$91.10M(+54.4%) | -$279.60M(+14.7%) |
| Mar 1995 | - | -$59.00M(-6.1%) | -$243.80M(-5.5%) |
| Dec 1994 | -$258.10M(+3810.6%) | -$62.80M(-5.8%) | -$258.10M(+38.7%) |
| Sep 1994 | - | -$66.70M(+20.6%) | -$186.10M(+92.3%) |
| Jun 1994 | - | -$55.30M(-24.6%) | -$96.80M(+261.2%) |
| Mar 1994 | - | -$73.30M(-896.7%) | -$26.80M(+306.1%) |
| Dec 1993 | -$6.60M(-105.3%) | $9.20M(-59.3%) | -$6.60M(+10.0%) |
| Sep 1993 | - | $22.60M(+53.7%) | -$6.00M(-287.5%) |
| Jun 1993 | - | $14.70M(-127.7%) | $3.20M(-150.8%) |
| Mar 1993 | - | -$53.10M(-641.8%) | -$6.30M(-105.0%) |
| Dec 1992 | $125.00M(+24.3%) | $9.80M(-69.2%) | $125.00M(+8.5%) |
| Sep 1992 | - | $31.80M(+511.5%) | $115.20M(+38.1%) |
| Jun 1992 | - | $5.20M(-93.4%) | $83.40M(+6.6%) |
| Mar 1992 | - | $78.20M(+414.5%) | $78.20M(-37.4%) |
| Dec 1991 | $100.60M(-19.5%) | - | - |
| Mar 1991 | - | $15.20M(-78.2%) | $124.90M(+12.0%) |
| Mar 1991 | $124.90M(+201.0%) | - | - |
| Dec 1990 | - | $69.80M(+167.4%) | $111.50M(+156.9%) |
| Sep 1990 | - | $26.10M(+89.1%) | $43.40M(+404.7%) |
| Jun 1990 | - | $13.80M(+666.7%) | $8.60M(-79.3%) |
| Mar 1990 | $41.50M(+105.4%) | $1.80M(+5.9%) | $41.50M(+4.5%) |
| Dec 1989 | - | $1.70M(-119.5%) | $39.70M(+4.5%) |
| Sep 1989 | - | -$8.70M(-118.6%) | $38.00M(-18.6%) |
| Jun 1989 | - | $46.70M | $46.70M |
| Mar 1989 | $20.20M | - | - |
FAQ
- What is Amgen annual cash flow from financing activities?
- What is the all time high annual CFF for Amgen?
- What is Amgen annual CFF year-on-year change?
- What is Amgen quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Amgen?
- What is Amgen quarterly CFF year-on-year change?
- What is Amgen TTM cash flow from financing activities?
- What is the all time high TTM CFF for Amgen?
- What is Amgen TTM CFF year-on-year change?
What is Amgen annual cash flow from financing activities?
The current annual CFF of AMGN is -$9.41B
What is the all time high annual CFF for Amgen?
Amgen all-time high annual cash flow from financing activities is $21.05B
What is Amgen annual CFF year-on-year change?
Over the past year, AMGN annual cash flow from financing activities has changed by -$30.46B (-144.73%)
What is Amgen quarterly cash flow from financing activities?
The current quarterly CFF of AMGN is -$4.11B
What is the all time high quarterly CFF for Amgen?
Amgen all-time high quarterly cash flow from financing activities is $21.51B
What is Amgen quarterly CFF year-on-year change?
Over the past year, AMGN quarterly cash flow from financing activities has changed by -$2.40B (-140.46%)
What is Amgen TTM cash flow from financing activities?
The current TTM CFF of AMGN is -$11.81B
What is the all time high TTM CFF for Amgen?
Amgen all-time high TTM cash flow from financing activities is $21.05B
What is Amgen TTM CFF year-on-year change?
Over the past year, AMGN TTM cash flow from financing activities has changed by -$9.64B (-444.67%)